Skip to main content

Peer Review reports

From: Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies

Original Submission
25 Nov 2021 Submitted Original manuscript
20 Apr 2022 Reviewed Reviewer Report - Olga Solovyeva
1 Jun 2022 Reviewed Reviewer Report - Research Square Reviewer 1
26 Sep 2022 Author responded Author comments - Max Topp
Resubmission - Version 2
26 Sep 2022 Submitted Manuscript version 2
3 Nov 2022 Reviewed Reviewer Report - Research Square Reviewer 1
3 Nov 2022 Reviewed Reviewer Report - Olga Solovyeva
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
5 Dec 2022 Editorially accepted
3 Jan 2023 Article published 10.1186/s13063-022-06982-7

You can find further information about peer review here.

Back to article page